Dr. Jennifer Harb Hanlon, MD

Dr. Hanlon practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Hanlon's NPI, 1891144911, was assigned on June 9, 2016. Dr. Hanlon graduated from Jacobs School of Medicine and Biomedical Sciences in 2016. Dr. Hanlon holds Florida license ME148287.

Dr. Hanlon's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Hanlon's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Hanlon is also affiliated with Baptist Health Baptist Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Hanlon to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanlon practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Hanlon's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Hanlon is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Hanlon's licenses on file in 3 states: Florida, Massachusetts and Rhode Island.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, larynx and vocal cord disease, swimmer's ear and tinnitus among the conditions Dr. Hanlon treats.

CMS data shows 531 Medicare services from Dr. Hanlon across 11 procedure codes in 2024, for 212 Medicare patients. Medicare paid $35,865 for them. Every service was in an office.

CMS counts 212 Medicare patients who saw Dr. Hanlon in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hanlon's median patient age at 48, with 58% women.

In 2024, Dr. Hanlon wrote 389 Medicare Part D claims for 161 patients. 93% of them were for generic drugs. CMS names the drug for 276 of them, across 12 drugs with 11 or more claims each, at $57,883 in total drug cost. In 2023, CMS named 256 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Hanlon for performance year 2024, reported as part of a group. Dr. Hanlon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 104 general payments to Dr. Hanlon from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 78% of the total. Sanofi and Genzyme US Companies paid the most, $2,065.

Dr. Hanlon graduated from Jacobs School of Medicine and Biomedical Sciences in 2016.

Dr. Hanlon is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.